Mitochondrial cytopathies and the kidney

Area of Science:

• Nephrology
• Genetics
• Mitochondrial Biology

Background:

• Mitochondrial cytopathies are a diverse group of disorders marked by impaired oxidative phosphorylation.
• Renal involvement in these conditions is more common than previously thought, often presenting subclinically or being overshadowed by other systemic symptoms.
• While historically considered pediatric diseases, adult-onset mitochondrial cytopathies are increasingly recognized.

Purpose of the Study:

• To review the spectrum of renal manifestations in mitochondrial cytopathies.
• To highlight the diagnostic and clinical significance of kidney involvement in these inherited metabolic disorders.
• To discuss specific genetic mutations and metabolic defects associated with renal pathology.

Main Methods:

• Literature review of mitochondrial cytopathies with renal involvement.
• Analysis of clinical presentations, including tubular and glomerular pathologies.
• Focus on specific genetic mutations (e.g., 3243 A>G) and treatable defects (coenzyme Q10 biosynthesis).

Main Results:

• Renal involvement is frequent, ranging from subclinical cases to severe kidney disease.
• Tubular defects, including electrolyte wasting and Fanconi syndrome, are common.
• Glomerular diseases, predominantly focal segmental glomerulosclerosis, are observed in a subset of patients.
• The 3243 A>G mutation is the most frequent cause of mitochondrial glomerulopathy.
• Coenzyme Q10 biosynthesis defects represent a treatable subset of mitochondrial cytopathies.

Conclusions:

• Renal involvement is an underappreciated but significant feature of mitochondrial cytopathies across all age groups.
• Early recognition of renal manifestations is crucial for comprehensive patient management.
• Specific genetic and metabolic factors contribute to distinct renal pathologies, offering avenues for targeted therapies.